Profile data is unavailable for this security.
About the company
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
- Revenue in USD (TTM)16.54bn
- Net income in USD-1.64bn
- Incorporated1944
- Employees33.89k
- LocationTeva Pharmaceutical Industries Ltd124 Dvora Hanevi'a St.TEL AVIV-YAFO 6944020IsraelISR
- Phone+972 39148213
- Fax+972 39234050
- Websitehttps://www.tevapharm.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Viatris Inc | 14.74bn | -634.20m | 11.52bn | 32.00k | -- | 0.6181 | 5.10 | 0.7815 | -0.5337 | -0.5337 | 12.30 | 15.61 | 0.3305 | 2.35 | 5.36 | 460,603.10 | -1.42 | -0.1756 | -1.68 | -0.2096 | 41.65 | 40.66 | -4.30 | -0.5768 | 0.9805 | 3.23 | 0.4297 | -- | -4.46 | 5.09 | -1,259.42 | -- | -3.10 | -- |
| Incyte Corp | 4.24bn | 32.62m | 13.70bn | 2.62k | 314.92 | 3.97 | 112.42 | 3.23 | 0.2248 | 0.2248 | 20.00 | 17.82 | 0.6938 | 4.74 | 5.31 | 1,620,641.00 | 0.5335 | 6.35 | 0.6981 | 7.89 | 93.20 | 94.43 | 0.769 | 9.56 | 1.94 | -- | 0.0109 | 0.00 | 14.76 | 14.46 | -94.54 | -40.76 | 2.02 | -- |
| Biomarin Pharmaceutical Inc | 2.85bn | 426.86m | 13.78bn | 3.04k | 32.85 | 2.44 | 26.33 | 4.83 | 2.20 | 2.20 | 14.38 | 29.66 | 0.4127 | 0.496 | 4.41 | 938,787.80 | 6.17 | 2.18 | 7.09 | 2.46 | 79.67 | 76.43 | 14.96 | 6.07 | 3.29 | -- | 0.0953 | 0.00 | 17.97 | 10.86 | 154.62 | -- | -9.83 | -- |
| Intra-Cellular Therapies Inc | 680.85m | -74.68m | 13.95bn | 860.00 | -- | 12.14 | -- | 20.50 | -0.7218 | -0.7218 | 6.60 | 10.81 | 0.6499 | 3.00 | 4.85 | 791,688.40 | -7.13 | -28.05 | -8.46 | -31.86 | 91.63 | 91.94 | -10.97 | -65.36 | 6.23 | -- | 0.00 | -- | 46.62 | 545.81 | 46.54 | -- | -14.39 | -- |
| Teva Pharmaceutical Industries Ltd (ADR) | 16.54bn | -1.64bn | 17.80bn | 33.89k | -- | 3.24 | -- | 1.08 | -1.45 | -1.45 | 14.63 | 4.74 | 0.3996 | 2.36 | 5.12 | 488,138.80 | -4.73 | -3.80 | -6.90 | -5.26 | 49.84 | 49.29 | -11.84 | -11.13 | 0.7459 | 4.29 | 0.7566 | -- | 4.40 | -0.4096 | -193.20 | -- | -1.05 | -- |
| Royalty Pharma plc | 2.26bn | 858.98m | 19.03bn | 99.00 | 17.22 | 2.80 | 56.91 | 8.41 | 1.92 | 1.92 | 3.81 | 11.79 | 0.1308 | -- | 71.18 | 22,864,400.00 | 7.69 | 7.56 | 10.14 | 10.21 | -- | -- | 58.79 | 55.06 | -- | -- | 0.424 | 46.51 | -3.86 | 4.52 | -24.31 | -18.22 | 7.80 | -- |
| Biogen Inc | 9.68bn | 1.63bn | 22.01bn | 7.61k | 13.45 | 1.31 | 9.46 | 2.27 | 11.18 | 11.18 | 66.30 | 114.73 | 0.3525 | 0.9264 | 4.88 | 1,272,308.00 | 5.95 | 9.02 | 7.11 | 10.69 | 76.12 | 81.00 | 16.87 | 21.25 | 0.9037 | 4.49 | 0.2736 | 0.00 | -1.62 | -7.62 | 40.57 | -22.63 | -11.68 | -- |
Data as of Mar 10 2025. Currency figures normalised to Teva Pharmaceutical Industries Ltd's reporting currency: US Dollar USD
28.12%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Fidelity Management & Research Co. LLCas of 31 Dec 2024 | 74.30m | 6.48% |
| Clal Pension & Provident Funds Ltd.as of 31 Dec 2024 | 38.96m | 3.40% |
| Ion Asset Management (Israel) Ltd.as of 31 Dec 2024 | 36.65m | 3.20% |
| BlackRock Fund Advisorsas of 31 Dec 2024 | 33.10m | 2.89% |
| Menora Mivtachim Insurance Ltd.as of 31 Dec 2024 | 28.38m | 2.48% |
| Lingotto Investment Management LLPas of 31 Dec 2024 | 27.19m | 2.37% |
| Migdal Insurance Co. Ltd. (Investment Portfolio)as of 31 Dec 2024 | 26.04m | 2.27% |
| Phoenix Investments House Ltd.as of 31 Dec 2024 | 21.21m | 1.85% |
| SSgA Funds Management, Inc.as of 31 Dec 2024 | 19.41m | 1.69% |
| Rubric Capital Management LPas of 31 Dec 2024 | 17.00m | 1.48% |
More ▼
Data from 31 Dec 2024 - 31 Dec 2024Source: FactSet Research Systems Inc.
